Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo ; volume:18 ; number:1 ; day:12 ; month:11 ; year:2018 ; pages:1-12 ; date:12.2018
BMC cancer ; 18, Heft 1 (12.11.2018), 1-12, 12.2018
- Creator
-
Ni, Jie
Cozzi, Paul
Beretov, Julia
Duan, Wei
Bucci, Joseph
Graham, Peter
Li, Yong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-5010-5
- URN
-
urn:nbn:de:101:1-2018121617364339991915
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ni, Jie
- Cozzi, Paul
- Beretov, Julia
- Duan, Wei
- Bucci, Joseph
- Graham, Peter
- Li, Yong
- SpringerLink (Online service)
Other Objects (12)
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Cytoplasmic domain of CD44 acts as a nuclear transcription regulator
Some Results on Weak KAM Theory for Time-periodic Tonelli Lagrangian Systems
Levinson’s Problem on Affine-Periodic Solutions
Risk factors of in-hospital death in patients with acute ST elevation myocardial infarction
Development and external validation of a diagnostic model for cardiometabolic-based chronic disease : results from the China health and retirement longitudinal study (CHARLS)
Prognostischer Einfluss von EpCAM beim Ovarialkarzinom
Expression of EpCAM in uveal melanoma
EpCAM expression dynamics in cancer progression
Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
EpCAM is critical for tumor proliferation and oxaliplatin chemoresistance in EpCAM high/CD44 + colorectal cancer stem cells
Untersuchungen zur Signaltransduktion des epithelialen Adhäsionsmoleküls EpCAM
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Cytoplasmic domain of CD44 acts as a nuclear transcription regulator
Some Results on Weak KAM Theory for Time-periodic Tonelli Lagrangian Systems
Levinson’s Problem on Affine-Periodic Solutions
Risk factors of in-hospital death in patients with acute ST elevation myocardial infarction
Development and external validation of a diagnostic model for cardiometabolic-based chronic disease : results from the China health and retirement longitudinal study (CHARLS)
Prognostischer Einfluss von EpCAM beim Ovarialkarzinom
Expression of EpCAM in uveal melanoma
EpCAM expression dynamics in cancer progression
Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
EpCAM is critical for tumor proliferation and oxaliplatin chemoresistance in EpCAM high/CD44 + colorectal cancer stem cells
Untersuchungen zur Signaltransduktion des epithelialen Adhäsionsmoleküls EpCAM
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Cytoplasmic domain of CD44 acts as a nuclear transcription regulator
Some Results on Weak KAM Theory for Time-periodic Tonelli Lagrangian Systems
Levinson’s Problem on Affine-Periodic Solutions
Risk factors of in-hospital death in patients with acute ST elevation myocardial infarction
Development and external validation of a diagnostic model for cardiometabolic-based chronic disease : results from the China health and retirement longitudinal study (CHARLS)
Prognostischer Einfluss von EpCAM beim Ovarialkarzinom
Expression of EpCAM in uveal melanoma
EpCAM expression dynamics in cancer progression
Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
EpCAM is critical for tumor proliferation and oxaliplatin chemoresistance in EpCAM high/CD44 + colorectal cancer stem cells